Clinical trials
Infection in ICU clinical trials
Below are recruiting infection in icu clinical trials, each written for real people, not researchers. We’re tracking 12 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06387667Recruiting
Fungal lung infections in ICU patients with weak immune systems
This study looks at different types of fungi that may cause serious lung infections in patients with weakened immune systems in the ICU. It aims to find out which fungi are present and which antifungal drugs can kill them.
AsyutAges 18 years+ - NCT06845865Recruiting
Gut barrier test in ICU patients with organ failure
This study looks at how the gut barrier works in people with severe infections that cause organ failure. It measures intestinal permeability using a simple test, to see if a 'leaky gut' contributes to how sick patients get.
VincennesAges 18 years+ - NCT06073834Recruiting
Lung infection study in ICU patients
This trial tests a new way to better understand lung infections in very sick ICU patients. It looks at people with septic shock, severe trauma, or major burns to see if an infection is the cause.
LyonAges 18 years+ - NCT06749483Recruiting
Gut bacteria and infection in intensive care patients
This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.
Jena, ThuringiaAges 18 years+ - NCT07395297Recruiting
Airway clearance therapy for ICU lung infections
This trial tests a new airway clearance device in ICU patients with pneumonia. It may help clear mucus from your lungs and improve breathing without needing a breathing tube.
Beijing, Beijing MunicipalityAges 18 years+ - NCT03580733RecruitingPhase 3
Caspofungin vs placebo for yeast infection in the belly (ICU)
This Phase 3 trial studies whether caspofungin (an antifungal medicine) helps treat suspected or confirmed yeast (candidiasis) infections inside the abdomen in ICU patients after surgery. You would either receive caspofungin or a placebo, and the goal is to see which option works better and is safe.
AmiensAges 18 years+ - NCT07183592Recruiting
Changing IV tubing in the ICU: does less often harm?
This trial compares changing the tubing attached to central lines every 4 days versus every 7 days, to see if less frequent changes cause more infections. If you have a central line in the ICU that will stay in for at least a week, this study may help decide the safest schedule.
Saint-Pierre, La RéunionAges 18 years+ - NCT07744321Recruiting
Bacteria in stool during long ICU stays
This study looks at how certain bacteria (Klebsiella pneumoniae and Enterobacter cloacae) change over time in the stool of ICU patients staying at least 28 days. It aims to understand why these infections occur and how they evolve, which could help improve future care.
CaenAges 18 years+ - NCT06774235RecruitingPhase 3
Interferon gamma to prevent infections in ICU patients
This trial tests if a drug called interferon gamma can help prevent new infections in ICU patients with a weakened immune system. It may help people who have been in the ICU for at least a week and have had multiple organ failure.
AngersAges 18 years+ - NCT06085690Recruiting
Reducing bloodstream infections from ICU catheters
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
Shanghai, Shanghai MunicipalityAges Any age - NCT07770347Enrolling by invitation
Sepsis and the immune system study
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06791889Recruiting
Tracking bacteria in blood of ICU sepsis patients
This study uses a highly sensitive blood test (DdPCR) to quickly find and monitor harmful bacteria in ICU patients with sepsis, aiming to improve early detection and treatment.
WuhanAges 18 years+
Hear when a new Infection in ICU trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infection in icu?
- Yes. Clin2 currently lists 12 recruiting infection in icu studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infection in icu trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infection in icu trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.